U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269808) titled 'Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration' on Nov. 26.
Brief Summary: This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Anesthesia
Sedation
Endoscopy
Intervention:
DRUG: Remimazolam
Remimazolam will be administered at 0.20 mg/kg for procedural sedation. The maximum initial bolus is 15 mg, with add...